Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Oncternal Therapeutics Inc have a median target of 18.00, with a high estimate of 39.00 and a low estimate of 2.00. The median estimate represents a 1,076.47% increase from the last price of 1.53.
High | 2,449.0% | 39.00 |
Med | 1,076.5% | 18.00 |
Low | 30.7% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate | +0.52% |
Average growth rate | +21.96% |
More ▼
Revenue history & estimates in USD
Average growth rate | +66.79% |
Average growth rate | -28.31% |
More ▼